On Tuesday, Shares of Johnson & Johnson (NYSE:JNJ), added 0.30% and closed at $117.01 in the last trading session. The last trading range of the stock ranges between $116.47 and $117.57. The company’s Market capitalization is $322.62 Billion with the total Outstanding Shares of 2.72 billion. As part of its longstanding commitment to Africa, Johnson & Johnson (JNJ) recently declared the launch of the Africa Innovation Challenge, an program to support Africa’s vibrant and growing innovation ecosystem and to assist develop important and locally sustainable consumer health solutions. The challenge is the most recent program in the company’s comprehensive approach to advancing health and innovation worldwide. The Johnson & Johnson Family of Companies’ presence in Africa dates back more than 80 years and includes business operations, public health programs and corporate citizenship.
“Through the Africa Innovation Challenge, we have the opportunity to support the continent’s top entrepreneurs through mentorship and other resources, and by working together with local talent, to bring forward new solutions to local health care challenges,” said Paul Stoffels, M.D., Executive Vice President and Chief Scientific Officer, Johnson & Johnson.
Earlier this year, Johnson & Johnson declared its global public health (GPH) strategy in Cape Town, South Africa, where its companies also opened their GPH operations headquarters. The operations expand upon the company’s legacy and presence in Africa, which began in 1936, and brings additional investments to the more than 1,500 employees and three manufacturing sites within the Johnson & Johnson Family of Companies already present on the continent.
Vereit Inc (NYSE:VER), dropped -0.22% and closed at $9.12 in the last trading session. The last trading range of the stock ranges between $9.01 and $9.15. The company’s Market capitalization is $9.17 Billion with the total Outstanding Shares of 974.18 million. VEREIT, Inc. (VER) declared that its Board of Directors declared a monthly dividend to holders of its 6.70% Series F Cumulative Redeemable Preferred Stock, par value $0.01 per share (“Series F Preferred Stock”), for January 2017 through March 2017 in respect of the periods included in the table below. The corresponding record and payment dates for each month’s Series F Preferred Stock dividend are also shown in the table below. The dividend for the Series F Preferred Stock accrues daily on a 360-day annual basis equal to an annualized dividend rate of $1.675 per share, or $0.1395833 per 30-day month.